Overview of ADAPTIR Immunotherapeutics

ADAPTIR Immunotherapeutics

The ADAPTIR™ (modular protein technology) platform is Emergent BioSolutions’ novel platform technology for generating immunotherapies that have the potential to address unmet treatment needs in multiple clinical areas, including autoimmune and inflammatory diseases and oncology.

Modular Protein Design

Emergent BioSolutions' custom ADAPTIR platform is designed to expand the utility and effectiveness of antibodies in new arenas.


Diversity and inclusion is an integral and inherent part of our culture. Diversity fuels our business growth while allowing us to attract, develop, and retain the best talent, to be more innovative in the products and services we develop, in the way we solve problems, and in the way we serve the needs of an increasingly global and diverse customer and partner base.


Subscribe to Emergent RSS